10 Results for "

Erk5 kinase inhibitor

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "Erk5 kinase inhibitor" in MCE Product Catalog:

7
7 Cited Publications
Cat. No.: HY-108886
CAS No.: 2250323-50-1
Purity:  99.15%
Target:  

ERK

Research Areas:  

Cancer

JWG-071 is the kinase-selective chemical probe for ERK5. JWG-071 inhibits ERK5 and LRRK2 with IC50 values of 88nM and 109 nM, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-112082
CAS No.: 2307249-33-6
Purity:  99.27%
Target:  

ERK

Research Areas:  

Cancer

BAY885, a chemical probe, is a highly potent and selective ERK5 inhibitor with an IC50 of 35 nM. BAY885 shows weak inhibition on others kinases .
loading...
    loading...
Cat. No.: HY-149616
CAS No.: 3032388-42-1
Target:  

PROTACs ERK

Research Areas:  

Cancer

PPM-3 is a highly selective ERK5 PROTAC degrader that mediates the degradation of ERK5 protein by recruiting VHL. PPM-3 inhibits ERK5 kinase activity with an IC50 of 62.4 nM. PPM-3-mediated ERK5 degradation exhibits a hook effect. PPM-3 exerts no significant direct inhibitory effect on the proliferation and migration of cancer cells. PPM-3 can be used in studies related to macrophage polarization and tumor immunity .
loading...
    loading...
Cat. No.: HY-156450
CAS No.: 2318792-30-0
Purity:  99.05%
Target:  

ERK

Research Areas:  

Cancer

ERK5-IN-5 (compound 4a) is an ERK5 kinase inhibitor with anticancer activity. ERK5-IN-5 exhibits good anti-proliferative activity with the IC50 value of 6.23 µg/mL for A549 cells .
loading...
    loading...
Cat. No.: HY-156451
CAS No.: 2734916-64-2
Target:  

ERK

Research Areas:  

Cancer

ERK5-IN-6 (compound 5J) is an ERK5 kinase inhibitor with anticancer activity. ERK5-IN-6 exhibits good anti-proliferative activity with the IC50 value of 4.56 µg/mL for A549 cells .
loading...
    loading...
Cat. No.: HY-150606
CAS No.: 1888305-17-6
Target:  

ERK

Research Areas:  

Cancer

ERK5-IN-4 (compound 34b) is a potent and selective inhibitor of extracellular signal-related kinase 5 (ERK5). ERK5-IN-4 inhibits ERK5 (full-length) and truncated ERK5 (ERK5 ΔTAD) kinase activity in HEK293 cells with an IC50 of 77 nM and 300 nM, respectively .
loading...
    loading...
Cat. No.: HY-150605
CAS No.: 1888305-85-8
Target:  

ERK

Research Areas:  

Cancer

ERK5-IN-3 (compound 33j) is a potent and selective ERK5 (extracellular signal-related kinase 5) inhibitor, with an IC50 of 6 nM. ERK5-IN-3 shows antiproliferation activity against Hela cells, with an IC50 of 31 nM .
loading...
    loading...
Cat. No.: HY-181477
ERK5-IN-7 is an orally active ERK5 inhibitor with an IC50 of 403.4 nM. ERK5-IN-7 directly inhibits ERK5 kinase activity, and downregulates the phosphorylation level and total protein expression of ERK5. ERK5-IN-7 induces Apoptosis (upregulates Bax, downregulates Bcl-2, and induces Caspase-3 cleavage). ERK5-IN-7 induces ROS accumulation. ERK5-IN-7 exhibits anticancer effects against Lewis lung cancer .
loading...
    loading...
Cat. No.: HY-108886R
CAS No.: 2250323-50-1
Target:  

Reference Standards ERK

Research Areas:  

Cancer

JWG-071 (Standard) is the analytical standard of JWG-071 (HY-108886). This product is intended for research and analytical applications. JWG-071 is the Kinase-selective chemical probe for ERK5. JWG-071 inhibits ERK5 and LRRK2 with IC50 values of 88nM and 109 nM, respectively .
loading...
    loading...
Cat. No.: HY-L010
1,154 compounds

MAPK families play an important role in complex cellular programs like proliferation, differentiation, development, transformation, and apoptosis. In mammalian cells, four MAPK families have been clearly characterized: ERK1/2, C-Jun N-terminal kinse/stress-activated protein kinase (JNK/SAPK) , p38 kinase and ERK5. They respond to different signals. Each MAPK-related cascade consists of three enzymes that are activated in series: a MAPK kinase kinase (MAPKKK), a MAPK kinase (MAPKK) and a MAP kinase (MAPK). MAPK signaling pathways has been implicated in the development of many human diseases including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS) and various types of cancers.

MCE designs a unique collection of 1,154 MAPK signaling pathway inhibitors that act as a useful tool for MAPK-related drug screening and disease research.